Head and neck cancers include a large and heterogeneous group of tumors with a very variable prognosis. These tumors arise from the squamous epithelial lining of the oral cavity, oropharynx, nasopharynx, hypopharynx, and larynx but include also lesions that arise from other anatomical sites, including the salivary glands, the mucosa of respiratory sinuses, thyroid, skin, and orbit. Sometimes, also cerebral tumors are included in this clinic-pathological chapter.
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The molecular mechanisms associated with the pathogenesis and evolution of these diseases are poorly understood, although some recent indications, from gene expression profiling studies, suggested a series of well-characterized and new biomarkers able to diagnose and predict behavior and sensitivity to treatment of head and neck cancers.
The expression analysis of these biomarkers associated with histomorphological data could then provide the oncologist with the opportunity to create a proper stratification of patients for customized therapies.
In this special issue the authors contributed to highlighting the appearance and the relative importance of new prognostic markers and of innovative surgical approaches in the prognostic determinism of several head and neck tumors. We hope that the information included in this special issue can contribute to understanding of mechanisms associated with the pathogenesis and evolution of head and neck tumors.
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